Paragonix Technologies is a medical device company specialized in organ preservation devices for the improvement of donor organ quality.
Paragonix Technologies has raised $24.0M in total funding. The most recent round was Series B. The last funding was announced in March 2023.
Paragonix Technologies's investors include Signet Healthcare Partners, Massachusetts Life Sciences Center.
Paragonix Technologies is headquartered in North Waltham, United States.
Paragonix Technologies is a medical device company specialized in organ preservation devices for the improvement of donor organ quality.
Paragonix Technologies is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Paragonix Technologies — Funding & Investors." VCBacked, March 7, 2023, https://www.vcbacked.co/company/paragonix-technologies. Accessed September 11, 2026.
VCBacked. (2023). Paragonix Technologies — Funding & Investors. Retrieved September 11, 2026, from https://www.vcbacked.co/company/paragonix-technologies
{{cite web |title=Paragonix Technologies — Funding & Investors |url=https://www.vcbacked.co/company/paragonix-technologies |website=VCBacked |access-date=September 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated